TAK1 deficiency attenuates cisplatin-induced acute kidney injury
- 1 January 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 318 (1) , F209-F215
Abstract
Cisplatin can cause acute kidney injury (AKI), but the molecular mechanisms are not well understood. The objective of the present study was to examine the role of transforming growth factor-β-activated kinase-1 (TAK1) in the pathogenesis of cisplatin-induced AKI. Wild-type mice and proximal tubule TAK1-deficient mice were treated with vehicle or cisplatin. Compared with wild-type control mice, proximal tubule TAK1-deficient mice had less severe kidney dysfunction, tubular damage, and apoptosis after cisplatin–induced AKI. Furthermore, conditional disruption of TAK1 in proximal tubular epithelial cells reduced caspase-3 activation, proinflammatory molecule expression, and JNK phosphorylation in the kidney in cisplatin-induced AKI. Taken together, cisplatin activates TAK1-JNK signaling pathway to promote tubular epithelial cell apoptosis and inflammation in cisplatin-induced AKI. Targeting TAK1 could be a novel therapeutic strategy against cisplatin-induced AKI.Keywords
Funding Information
- NIH (R01DK95835)
- US Department of Veterans Affairs (I01BX02650)
This publication has 37 references indexed in Scilit:
- Genetic deficiency of adiponectin protects against acute kidney injuryKidney International, 2013
- Apoptosis and acute kidney injuryKidney International, 2011
- Acute inhibition of TAK1 protects against neuronal death in cerebral ischemiaCell Death & Differentiation, 2011
- JNK signaling in apoptosisOncogene, 2008
- TAK1 Regulates Reactive Oxygen Species and Cell Death in Keratinocytes, Which Is Essential for Skin IntegrityJournal of Biological Chemistry, 2008
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategiesKidney International, 2008
- A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathwayProceedings of the National Academy of Sciences, 2006
- Cisplatin nephrotoxicitySeminars in Nephrology, 2003
- Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent PathwaysThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to developmentCurrent Opinion in Cell Biology, 1998